NCT05813275 Phase 3 Completed
Parallel-Arm Study to Compare AD109 to Placebo With Patients With OSA (SynAIRgy Study) Study sponsor: Apnimed
Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.
Changes Study details Primary completion 2025-03-10 Actual
Enrollment · participants 646 Actual
Source updated 2026-09-11 Last update listed in the registry record
Version history
Changes to this trial Last 12 months
Posted 2026-09-11 · 1 field changed
Main study measure wording changed
Text changed; whether the study measures changed has not been verified. Saved text may be shortened.
Compare wording
− Before Measure: Change from Baseline in Apnea-Hypopnea Index (AHI)
+ After Measure: Change From Baseline in Apnea-Hypopnea Index (AHI)
Check registry source
Posted 2025-11-21 · 1 field changed
Main study measure wording changed
Text changed; whether the study measures changed has not been verified. Saved text may be shortened.
Compare wording
− Before Measure: Efficacy of AD109 on airway obstruction in mild to sever OSA
+ After Measure: Change from Baseline in Apnea-Hypopnea Index (AHI)
Check registry source
This database covers selected trials and recorded edits. Some past edits may be missing, and saved text about the main study measures (endpoints) may be shortened. Check the original registry record when a detail matters. Read our methodology
Trial